Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

被引:11
|
作者
Accorsi, Patrizia [1 ]
Berti, Pierluigi [2 ]
de Angelis, Vincenzo [3 ]
De Silvestro, Giustina [4 ]
Mascaretti, Luca [5 ]
Ostuni, Angelo [6 ]
机构
[1] Dept Haematol Transfus Med & Biotechnol, Osped Civile, Pescara, Italy
[2] Umberto Parini Hosp, Immunohaematol & Transfus Med, Aosta, Italy
[3] Azienda Sanit Univ Friuli Cent, Transfus Med Dept, Udine, Italy
[4] Univ Hosp Padua, Blood Transfus Serv, Padua, Italy
[5] Azienda Sanit Univ Giuliano Isontina, Transfus Med Dept, Trieste, Italy
[6] Univ Hosp Policlin, Transfus Med Unit, Bari, Italy
关键词
COVID-19; Immune plasma; CONVALESCENT PLASMA; THERAPY;
D O I
10.1016/j.transci.2020.102817
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19
    Accorsi, Patrizia
    Berti, Pierluigi
    de Angelis, Vincenzo
    De Silvestro, Giustina
    Mascaretti, Luca
    Ostuni, Angelo
    BLOOD TRANSFUSION, 2020, 18 (03) : 163 - 166
  • [2] Position paper on the use of COVID-19 convalescent plasma: an update
    Prati, Daniele
    Fiorin, Francesco
    Berti, Pierluigi
    De Silvestro, Giustina
    Accorsi, Patrizia
    Ostuni, Angelo
    BLOOD TRANSFUSION, 2021, 19 (04) : 277 - 280
  • [3] Perspectives for immune plasma treatment of COVID-19
    Sayinalp, Basak
    Cinar, Olgu Erkin
    Haznedaroglu, Ibrahim Celattin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 1 - 9
  • [4] Treatment with Dexamethasone in Patients with COVID-19 A Position Paper of the German Respiratory Society (DGP)
    Kolditz, M.
    Dellweg, D.
    Geerdes-Fenge, H.
    Lepper, P. M.
    Schaberg, T.
    Ewig, S.
    Pfeifer, M.
    Bauer, T.
    PNEUMOLOGIE, 2020, 74 (08): : 493 - 495
  • [5] COVID-19-vaccinated plasma treatment for COVID-19 patients?
    Alberca, Gabriela Gama Freire
    Alberca, Ricardo Wesley
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (04) : 552 - 553
  • [6] Immune treatment in COVID-19
    Menendez, Rosario
    Gonzalez, Paula
    Latorre, Ana
    Mendez, Raul
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 59 - 63
  • [7] Epidemic of Mucormycosis in COVID-19 Pandemic: A Position Paper
    Kulkarni, Rahul
    Misra, Usha K.
    Meshram, Chandrashekhar
    Kochar, Dhanpat
    Modi, Manish
    Vishnu, Venugopalan Y.
    Garg, Ravindra K.
    Surya, Nirmal
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (01) : 7 - 10
  • [8] HISTORY OF PLASMA THERAPY: A CURRENTLY USED TREATMENT OPTION FOR COVID-19
    Bilir, Esra
    Vatanoglu Lutz, Emine
    Akalin, Ayse Arzu
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2021, 84 (03): : 411 - 414
  • [9] Treatment of immunocompromised COVID-19 patients with convalescent plasma
    Fung, Monica
    Nambiar, Ashok
    Pandey, Suchi
    Aldrich, J. Matthew
    Teraoka, Justin
    Freise, Christopher
    Roberts, John
    Chandran, Sindhu
    Hays, Steven R.
    Bainbridge, Emma
    DeVoe, Catherine
    Roque Gardner, Annelys
    Yokoe, Deborah
    Henrich, Timothy J.
    Babik, Jennifer M.
    Chin-Hong, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (02)
  • [10] Is convalescent plasma an alternative treatment for Covid-19 patients?
    Enrique Trejo-Gomora, Jorge
    Dimas-Gonzalez, Jisela
    Lagunas-Martinez, Alfredo
    SALUD PUBLICA DE MEXICO, 2020, 62 (06): : 870 - 871